Immunome Financial Overview
Immunome's market cap is currently $2.46B. The company's EPS TTM is $-0.65; its P/E ratio is -7.55; Immunome is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.59. See an overview of income statement, balance sheet, and cash flow financials.
